US Patent Litigations are now available. Check here

Explore Celator Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3300601Jan 12, 2022Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders3
EP2768484Jul 24, 2019Lyophilized Liposomes2
EP2120568Nov 15, 2017Fixed Drug Ratios For Treatment Of Hematopoietic Cancers And Proliferative Disorders2